Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma

Clinical trial NCT00005951 · COMPLETED

Trial details

NCT number: NCT00005951
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2000-08-01
Primary completion: 2006-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.